Convalescent Plasma

Emande, and i think we do want to clarify, because the two arthe agents that the i d s a guide lines do recommend when, if i can call them first line agents that doctor gondy mention, are not available. The evidence supporting the recommendations for convalescent plasma comes from only three small stedies,. That has a low certainty and that it may actually reduce ospitalizations, and it doesn't really have any mortality benefit, at least with the data that is available. We also know that even the monloperavea study is based on one study, which is the moveout study.